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Prolapsing mucosal polyp: A form of patients  undergoing  colonoscopic  evaluation  as  large  redun-
dant  hyperemic  mucosal  folds  that  mimic  the  appearance
of  a  polypoid  mass  projecting  into  the  lumen  of  the  sig-
moid  colon.  Due  to  under-recognition  or  misdiagnosis  of
said  lesion,  its  true  prevalence  at  endoscopic  evaluation  is
unknown.
Prolapsing  mucosal  polyps  form  part  of  the  spectrum  of
lesions  called  ‘‘mucosal  prolapse  syndrome’’.  That  term
was  proposed  in  1977  by  Du  Boulay  et  al.  to  encom-
pass  a  variety  of  disorders  with  similar  clinical  and
histologic  characteristics.1 The  proposed  conditions  that
make  up  part  of  the  so-called  mucosal  prolapse  syndrome
include  solitary  rectal  ulcer  syndrome,2--4 gastric  antral
vascular  ectasia,5 inflammatory  cloacogenic  polyps,4 inflam-
matory’’cap’’  polyps,6 and  prolapsing  mucosal  polyps,6 all
of  which  share  similar  histologic  features.7
Prolapsing  mucosal  polyps  have  been  described  to


























Currently,  there  is  no  consensus  on  the  standard  treat-
ment  of  prolapsing  mucosal  polyps.  Some  reports  havecolonic polyp not to be forgotten
Pólipo prolapsado de mucosa: una forma de
pólipo del colon que no debe ser olvidada
Prolapsing  mucosal  polyps  of  the  colon  are  an  uncom-
mon  finding  during  colonoscopy.  However,  when  present,
those  lesions,  which  are  a  form  of  colonic  polyps,  are
frequently  unrecognized  and  misdiagnosed  as  neoplastic
lesions,  sometimes  leading  to  unnecessary  endoscopic  or
surgical  resection.
We  present  herein  a  case  of  symptomatic  prolapsing
mucosal  polyp  of  the  colon.  We  also  reviewed  the  clinical,
endoscopic,  and  histopathologic  characteristics,  as  well  as
the  potential  management,  of  that  entity.
A  62-year-old  woman  with  no  relevant  past  medical
history  was  referred  to  our  outpatient  clinic  for  resection  of
a  polypoid  lesion,  previously  detected  during  colonoscopy,
that  was  located  in  the  sigmoid  colon.  She  had  a  6-month
history  of  nonspecific  gastrointestinal  symptoms  consisting
of  constipation  and  abdominal  bloating.  Physical  examina-
tion  revealed  mild  abdominal  tenderness  in  the  left  lower
quadrant  upon  palpation.  Laboratory  tests  were  within
normal  range.
At  flexible  rectosigmoidoscopy,  we  found  a  2  cm,  lobu-
lated,  bright,  hyperemic  mass  projecting  into  the  lumen  of
the  sigmoid  colon,  with  the  morphologic  characteristics  of
a  polyp  (Paris  Ip  --  pedunculated  polyp).  It  had  a  broad  stalk
with  normal  surrounding  mucosa,  as  shown  in  fig.  1.  We  also
observed  a  spastic  colon  and  associated  sigmoid  diverticula.
Hot  snare  polypectomy  was  performed.
The  pathology  analysis  of  the  resected  lesion,  as  shown  in
fig.  2,  identified  glandular  crypt  abnormalities  and  a  thick-
ened  muscularis  mucosae,  with  fibromuscular  obliteration  of
the  lamina  propria,  all  of  which  are  characteristic  features
of  a  prolapsing  mucosal  polyp.
The  patient  was  treated  with  a  high-fiber  diet,  reporting
symptom  resolution,  along  with  normal  bowel  movement
frequency  and  stool  consistency.
Prolapsing  mucosal  polyps  are  the  result  of  chronic  pro-
lapse  of  the  intestinal  mucosa.  They  have  been  described  in
 Please cite this article as: Monreal-Robles R, González-González
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isease. The  exact  mechanism  leading  to  the  forma-
ion  of  a  prolapsing  mucosal  polyp  is  uncertain.  However,
n  patients  with  a  long  history  of  defecation  straining,  a
ombination  of  venous  congestion  and  mucosal  redundancy
econdary  to  repeated  colonic  spastic  contractions  is  the
ost  probable  mechanism.8--10 In  the  largest  case  series
vailable,  Tendler  et  al.11 reported  on  15  patients  with
rolapsing  mucosal  polyps  in  the  sigmoid  colon,  describing
heir  clinical,  endoscopic,  and  histologic  features.  Occult
astrointestinal  bleeding,  hematochezia,  cramping  abdom-
nal  pain,  and  altered  bowel  habits  were  the  most  frequent
resenting  symptoms.  The  main  endoscopic  features  were
he  presence  of  hyperemic  polyps  and  prominent  redundant
olds  with  petechiae,  all  involving  the  sigmoid  colon.  The
ost  frequently  encountered  histopathologic  findings  were
landular  crypt  abnormalities  (hyperplasia,  branching,  elon-
ation,  distortion)  in  100%,  fibromuscular  obliteration  of  the
amina  propria  in  93%,  hypertrophy  and  extension  of  fibro-
uscular  tissue  into  the  lamina  propria  in  87%,  and  mucosal
apillary  abnormalities  (congestion,  hyalinization,  thrombo-
is,  dilation)  in  87%.
Common  differential  diagnoses  in  patients  with  prolaps-
ng  mucosal  polyps  are  adenomatous  polyps,  malignancy,
lcerative  colitis,  and  hemangiomas.  To  the  best  of  our
nowledge  there  are  no  reports  of  malignant  transformation
f  prolapsing  mucosal  polyps.hown  that  conservative  management  based  on  a  high-fiber
iet  results  in  a  significant  regression  of  those  hyperemic
olypoid  lesions.10 Their  clinical  significance  lies  in  the  fact
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igure  1  Sequential  images  of  the  endoscopic  appearance  of
) Obliteration  of  the  lumen  and  long-standing  spasm  are  pre
etraction of  the  prolapsing  mucosal  polyp  that  continues  wit
yperemic mucosa  to  normal-looking  surrounding  mucosa.  D)  La
etechiae (arrows).
hat  they  may  be  responsible  for  recurrent/persistent  overt
r  occult  bleeding  and/or  obstructive  symptoms,  settings  in
hich  surgical  resection  is  a  reasonable  option.  Long-term
ollow-up  studies  are  needed  to  establish  the  significance
nd  appropriate  management  of  said  hyperemic  polypoid
esions.igure  2  Anatomopathologic  analysis  of  the  specimen.  A)  Panoram
ucosal thickening.  C)  Glandular  abnormalities.  D)  Thickening  of  thSCIENTIFIC  LETTERS
olapsing  mucosal  polyp.  A)  Lobulated,  bright,  hyperemic  mass.
,  showing  a  prolapsing  mucosal  polyp  with  a  broad  stalk.  C)
dundant  mucosal  folds.  Notice  the  transition  from  congestive
 aspect  of  the  lesion  showing  the  redundant  mucosal  folds  with
Based  on  the  best  available  data,  endoscopists  and
athologists  should  be  familiarized  with  and  recognize
he  characteristic  features  of  prolapsing  mucosal  polyps,
o  prevent  the  morbidity  and  related  costs  of  unnec-
ssary  endoscopic  follow-up,  polypectomy,  or  surgical
esection.ic  view  of  the  specimen.  B)  Chronic  inflammatory  infiltrate  and
e  muscularis  mucosae.
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Gastrointestinal mucormycosis: An
atypical cause of abdominal pain in
an immunocompromised patient
Mucormicosis gastrointestinal: causa atípica
de dolor abdominal en un paciente
inmunocomprometido
presents  as  a  nonspecific  manifestation  due  to  the  inability
of  the  patient  to  mount  an  adequate  immune  response.
Immunocompromised  patients  are  those  that  have
chronic  diseases  managed  through  immunomodulators  and
that  suffer  from  an  alteration  in  the  immune  response
that  is  innate  or  secondary  to  some  other  pathology.  That
group  of  patients  includes  persons  that  are  advanced  in
age,  that  have  diabetes  mellitus,  HIV  infection,  or  neopla-
sia.  It  also  includes  transplanted  patients  and  those  thatAbdominal  pain  in  immunocompromised  patients  is  a  diag-
nostic  and  therapeutic  challenge  for  clinicians  because  it
 Please cite this article as: Clemente-Gutiérrez U, Perez-Soto
RH, Álvarez-Bautista FE, Domínguez-Rosado I, Cuellar-Mendoza M.
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ake  medications  that  modify  the  immune  response,  such
s  steroids,  anti-TNF  alpha,  methotrexate,  cyclosporine,
nd  tacrolimus,  among  others.1 Myelosuppression  is  a  major
ystemic  toxicity  generally  associated  with  chemotherapy
reatments.  It  considerably  increases  morbidity  and  mortal-
ty,  as  well  as  delays  in  oncologic  treatment,  thus  altering
verall  survival  in  those  patients.2A  38-year-old  woman  diagnosed  with  acute  myeloid
eukemia  sought  medical  attention  at  the  emergency  service
ue  to  painful  abdominal  syndrome.  The  patient  was  in
